WENDY ALEXANDER: Open Payments
NPI 1205372182 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,398 in 97 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $530 · 2025 $2,398
Food & beverage: $2,398
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 29 | $934 |
| Gilead Sciences, Inc. | 18 | $495 |
| Ipsen Biopharmaceuticals, Inc | 12 | $276 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $242 |
| Mallinckrodt Hospital Products Inc. | 1 | $122 |
| Intercept Pharmaceuticals, Inc. | 4 | $87 |
| ABBVIE INC. | 4 | $76 |
| ORPHALAN INC | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Novo Nordisk Inc | 2 | $44 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, TERLIVAZ, OCALIVA, MAVYRET, CUVRIOR, Wegovy.
Industry payments across TX — which companies pay providers there.
